Chronic continuous exenatide infusion does not cause pancreatic inflammation and ductal hyperplasia in non-human primates

American Journal of Pathology

Volumn 185, Issue 1, 2015, Pages 139-150

  Fiorentino, Teresa Vanessa ^a,b   Owston, Michael ^c   Abrahamian, Gregory ^a   La Rosa, Stefano ^d   Marando, Alessandro ^d   Perego, Carla ^e   Di Cairano, Eliana S ^e   Finzi, Giovanna ^d   Capella, Carlo ^d   Sessa, Fausto ^d   Casiraghi, Francesca ^a,f   Paez, Ana ^a   Adivi, Ashwin ^a   Davalli, Alberto ^a,g   Fiorina, Paolo ^h   Guardado Mendoza, Rodolfo ^a,i,l   Comuzzie, Anthony G ^j   Sharp, Mark ^c   Defronzo, Ralph A ^a   Halff, Glenn ^a   Dick, Edward J ^c   Folli, Franco ^a,j,k   more..

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^d UNIVERSITY OF INSUBRIA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF GUANAJUATO   (Mexico)

^j SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^k UNIVERSITY OF CAMPINAS   (Brazil)

^l Research Department Hospital Regional de Alta Especialidad Del Bajío   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CD3 ANTIGEN; EXENDIN 4; INSULIN; KI 67 ANTIGEN; LOW DENSITY LIPOPROTEIN; SODIUM CHLORIDE; STEM CELL FACTOR; ZYMOGEN GRANULE; ANTIDIABETIC AGENT; PEPTIDE; VENOM;

ACINAR CELL; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY MASS; CELL COUNT; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; COMPUTER ASSISTED STEREOLOGY TOLLBOX MORPHOMETRY; CONTINUOUS INFUSION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; FEMALE; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LIPID BLOOD LEVEL; MALE; MONONUCLEAR CELL; MONONUCLEAR INFLAMMATORY CELL ACCUMULATION; MORPHOMETRICS; NONHUMAN; ORGAN WEIGHT; PANCREAS ADENOMA; PANCREAS DYSPLASIA; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PANCREAS RESECTION; PANCREAS WEIGHT; PANCREATITIS; PAPIO HAMADRYAS; PHENOTYPE; PRIMATE; T LYMPHOCYTE; WAIST CIRCUMFERENCE; ANIMAL; BABOON; BLOOD; CYTOLOGY; EXOCRINE PANCREAS; FLUORESCENCE MICROSCOPY; HYPERPLASIA; INFLAMMATION; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PANCREATIC DUCT; PATHOLOGY;

AMYLASES; ANIMALS; APOPTOSIS; FEMALE; HYPERPLASIA; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFUSIONS, INTRAVENOUS; INSULIN RESISTANCE; KI-67 ANTIGEN; MALE; MICROSCOPY, FLUORESCENCE; PANCREAS, EXOCRINE; PANCREATIC DUCTS; PAPIO; PEPTIDES; PHENOTYPE; VENOMS;

EID: 84918828271     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.09.009     Document Type: Article

References (49)

1. G. Xu, D.A. Stoffers, J.F. Habener, and S. Bonner-Weir Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats Diabetes 48 1999 2270 2276
2. L. Farilla, H. Hui, C. Bertolotto, E. Kang, A. Bulotta, U. Di Mario, and R. Perfetti Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats Endocrinology 143 2002 4397 4408
3. H. Hui, C. Wright, and R. Perfetti Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells Diabetes 50 2001 785 796
4. M.S. Fineman, T.A. Bicsak, L.Z. Shen, K. Taylor, E. Gaines, A. Varns, D. Kim, and A.D. Baron Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes Diabetes Care 26 2003 2370 2377
5. J.E. Campbell, and D.J. Drucker Pharmacology, physiology, and mechanisms of incretin hormone action Cell Metab 17 2013 819 837
6. B.J. Goldstein, M.N. Feinglos, J.K. Lunceford, J. Johnson, D.E. Williams-Herman Sitagliptin 036 Study Group Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes Diabetes Care 30 2007 1979 1987
7. J.J. Meier GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus Nat Rev Endocrinol 8 2012 728 742
8. J.J. Meier, and M.A. Nauck Risk of pancreatitis in patients treated with incretin-based therapies Diabetologia 57 2014 1320 1324
9. C.E. Forsmark, and J. Billie AGA institute technical review on acute pancreatitis Gastroenterology 132 2007 2022 2044
10. C.J. Girman, T.D. Kou, B. Cai, C.M. Alexander, E.A. O'Neill, D.E. Williams-Herman, and L. Katz Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes Diabetes Obes Metab 12 2010 766 771
11. Q. Ben, M. Xu, X. Ning, J. Liu, S. Hong, W. Huang, H. Zhang, and Z. Li Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies Eur J Cancer 47 2011 1928 1937
12. M.A. Nauck A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks Diabetes Care 36 2013 2126 2132
13. M. Monami, I. Dicembrini, C. Nardini, I. Fiordelli, and E. Mannucci Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials Diabetes Res Clin Pract 103 2014 269 275
14. M. Monami, I. Dicembrini, and E. Mannucci Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials Diabetes Obes Metab 16 2014 48 56
15. M. Wenten, J.A. Gaebler, M. Hussein, E.M. Pelletier, D.B. Smith, P. Girase, R.A. Noel, D.K. Braun, and G.L. Bloomgren Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study Diabet Med 29 2012 1412 1418
16. R. Garg, W. Chen, and M. Pendergrass Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis Diabetes Care 33 2010 2349 2354
17. D.J. Drucker, S.I. Sherman, R.M. Bergenstal, and J.B. Buse The safety of incretin-based therapies: review of the scientific evidence J Clin Endocrinol Metab 96 2011 2027 2031
18. M. Elashoff, A.V. Matveyenko, B. Gier, R. Elashoff, and P.C. Butler Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies Gastroenterology 141 2011 150 156
19. L. Macconell, C. Brown, K. Gurney, and J. Han Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials Diabetes Metab Syndr Obes 5 2012 29 41
20. W.B. White, C.P. Cannon, S.R. Heller, S.E. Nissen, R.M. Bergenstal, G.L. Bakris, A.T. Perez, P.R. Fleck, C.R. Mehta, S. Kupfer, C. Wilson, W.C. Cushman, F. Zannad EXAMINE Investigators Alogliptin after acute coronary syndrome in patients with type 2 diabetes N Engl J Med 369 2013 1327 1335
21. B.M. Scirica, D.L. Bhatt, E. Braunwald, P.G. Steg, J. Davidson, B. Hirshberg, P. Ohman, R. Frederich, S.D. Wiviott, E.B. Hoffman, M.A. Cavender, J.A. Udell, N.R. Desai, O. Mosenzon, D.K. McGuire, K.K. Ray, L.A. Leiter, I. Raz SAVOR-TIMI 53 Steering Committee and Investigators Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N Engl J Med 369 2013 1317 1326
22. D.J. Drucker, S.I. Sherman, F.S. Gorelick, R.M. Bergenstal, R.S. Sherwin, and J.B. Buse Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits Diabetes Care 33 2010 428 433
23. A.E. Butler, M. Campbell-Thompson, T. Gurlo, D.W. Dawson, M. Atkinson, and P.C. Butler Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors Diabetes 62 2013 2595 2604
24. E. Harja, J. Lord, and J.S. Skyler An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology Diabetes Technol Ther 15 2013 609 618
25. S. Bonner-Weir, P.A. In't Veld, and G.C. Weir Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies Diabetes Obes Metab 16 2014 661 666
26. J.S. Nachnani, D.G. Bulchandani, A. Nookala, B. Herndon, A. Molteni, P. Pandya, R. Taylor, T. Quinn, L. Weide, and L.M. Alba Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas Diabetologia 53 2010 153 159
27. A.V. Matveyenko, S. Dry, H.I. Cox, A. Moshtaghian, T. Gurlo, R. Galasso, A.E. Butler, and P.C. Butler Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin Diabetes 58 2009 1604 1615
28. B. Gier, A.V. Matveyenko, D. Kirakossian, D. Dawson, S.M. Dry, and P.C. Butler Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras (G12D) mouse model Diabetes 61 2012 1250 1262
29. K. Tatarkiewicz, P.A. Smith, E.J. Sablan, C.J. Polizzi, D.E. Aumann, C. Villescaz, D.M. Hargrove, B.R. Gedulin, M.G. Lu, L. Adams, T. Whisenant, D. Roy, and D.G. Parkes Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents Am J Physiol Endocrinol Metab 299 2010 E1076 E1086
30. N.C. Nyborg, A.M. Mølck, L.W. Madsen, and L.B. Knudsen The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species Diabetes 61 2012 1243 1249
31. N. Vrang, J. Jelsing, L. Simonsen, A.E. Jensen, I. Thorup, H. Søeborg, and L.B. Knudsen The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis Am J Physiol Endocrinol Metab 303 2012 E253 E264
32. A.O. Chavez, J.C. Lopez-Alvarenga, M.E. Tejero, C. Triplitt, R.A. Bastarrachea, A. Sriwijitkamol, P. Tantiwong, V.S. Voruganti, N. Musi, A.G. Comuzzie, R.A. DeFronzo, and F. Folli Physiological and molecular determinants of insulin action in the baboon Diabetes 57 2008 899 908
33. R. Guardado-Mendoza, A.M. Davalli, A.O. Chavez, G.B. Hubbard, E.J. Dick, A. Majluf-Cruz, C.E. Tene-Perez, L. Goldschmidt, J. Hart, C. Perego, A.G. Comuzzie, M.E. Tejero, G. Finzi, C. Placidi, S. La Rosa, C. Capella, G. Halff, A. Gastaldelli, R.A. DeFronzo, and F. Folli Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons Proc Natl Acad Sci U S A 106 2009 13992 13997
34. R. Guardado-Mendoza, L. Jimenez-Ceja, A. Majluf-Cruz, S. Kamath, T.V. Fiorentino, F. Casiraghi, A.O. Velazquez, R.A. DeFronzo, E. Dick, A. Davalli, and F. Folli Impact of obesity severity and duration on pancreatic α- and β-cells dynamics in normoglycemic non-human primates Int J Obes (Lond) 37 2013 1071 1078
35. S. Kamath, A.O. Chavez, A. Gastaldelli, F. Casiraghi, G.A. Halff, G.A. Abrahamian, A.M. Davalli, R.A. Bastarrachea, A.G. Comuzzie, R. Guardado-Mendoza, L.M. Jimenez-Ceja, V. Mattern, A.M. Paez, A. Ricotti, M.E. Tejero, P.B. Higgins, I.P. Rodriguez-Sanchez, D. Tripathy, R.A. DeFronzo, E.J. Dick Jr., G.W. Cline, and F. Folli Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates PLoS One 6 2011 e27617
36. F. Casiraghi, R. Lertwattanarak, L. Luzi, A.O. Chavez, A.M. Davalli, T. Naegelin, A.G. Comuzzie, P. Frost, N. Musi, and F. Folli Energy expenditure evaluation in humans and non-human primates by SenseWear Armband: validation of energy expenditure evaluation by SenseWear Armband by direct comparison with indirect calorimetry PLoS One 8 2013 e73651
37. Y.R. Bommineni, E.J. Dick Jr., A.R. Malapati, M.A. Owston, and G.B. Hubbard Natural pathology of the Baboon (Papio spp.) J Med Primatol 40 2011 142 155
38. R. Guardado-Mendoza, E.J. Dick Jr., L.M. Jimenez-Ceja, A. Davalli, A.O. Chavez, F. Folli, and G.B. Hubbard Spontaneous pathology of the baboon endocrine system J Med Primatol 38 2009 383 389
39. A.M. Coelho Jr., and K.D. Carey A social tethering system for nonhuman primates used in laboratory research Lab Anim Sci 40 1990 388 394
40. H.M. McClure, and F.W. Chandler A survey of pancreatic lesions in nonhuman primates Vet Pathol Suppl 7 1982 193 209
41. C.A. Mandarim-de-Lacerda Stereological tools in biomedical research An Acad Bras Cienc 75 2003 469 486
42. A.R. Quinn, C.L. Blanco, C. Perego, G. Finzi, S. La Rosa, C. Capella, R. Guardado-Mendoza, F. Casiraghi, A. Gastaldelli, M. Johnson, E.J. Dick Jr., and F. Folli The ontogeny of the endocrine pancreas in the fetal/newborn baboon J Endocrinol 214 2012 289 299
43. R.H. Hruban, N.V. Adsay, J. Albores-Saavedra, C. Compton, E.S. Garrett, S.N. Goodman, S.E. Kern, D.S. Klimstra, G. Klöppel, D.S. Longnecker, J. Lüttges, and G.J. Offerhaus Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions Am J Surg Pathol 25 2001 579 586
44. R.H. Hruban, K. Takaori, D.S. Klimstra, N.V. Adsay, J. Albores-Saavedra, A.V. Biankin, S.A. Biankin, C. Compton, N. Fukushima, T. Furukawa, M. Goggins, Y. Kato, G. Klöppel, D.S. Longnecker, J. Lüttges, A. Maitra, G.J. Offerhaus, M. Shimizu, and S. Yonezawa An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms Am J Surg Pathol 28 2004 977 987
45. S. Bonner-Weir, A. Inada, S. Yatoh, W.C. Li, T. Aye, E. Toschi, and A. Sharma Transdifferentiation of pancreatic ductal cells to endocrine beta-cells Biochem Soc Trans 36 2008 353 356
46. A.G. Egan, E. Blind, K. Dunder, P.A. de Graeff, B.T. Hummer, T. Bourcier, and C. Rosebraugh Pancreatic safety of incretin-based drugs: FDA and EMA assessment N Engl J Med 370 2014 794 797
47. A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, and P.C. Butler Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 2003 102 110
48. T. Mezza, G. Muscogiuri, G.P. Sorice, G. Clemente, J. Hu, A. Pontecorvi, J.J. Holst, A. Giaccari, and R.N. Kulkarni Insulin resistance alters islet morphology in non-diabetic humans Diabetes 63 2014 994 1007
49. T. Holland, and C. Holland Unbiased histological examinations in toxicological experiments (or, the informed leading the blinded examination) Toxicol Pathol 39 2011 711 714